Search for Clinical Trial Results
Neurofibroma - 181 Studies Found
Status | Study |
Completed |
Study Name: Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1 Condition:
|
Completed |
Study Name: Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas Condition:
|
Recruiting |
Study Name: Photodynamic Therapy for Benign Dermal Neurofibromas Condition: NEUROFIBROMATOSIS 1 Date: 2016-03-25 Interventions: Procedure: PDT Treatment Drug: Levulan Kerastick |
Completed |
Study Name: Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas Condition:
|
Completed |
Study Name: Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1 Condition: Neurofibromatosis Date: 2008-09-16 Interventions: Drug: Pirfenidone Capsule 800 mg TID, oral |
Recruiting |
Study Name: Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs) Condition:
|
Recruiting |
Study Name: Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery Condition:
|
Active, not recruiting |
Study Name: Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1) Condition: Neurofibromatoses Date: 2012-09-05 Interventions:
|
Recruiting |
Study Name: Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain Condition:
|
Completed |
Study Name: A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas Condition: Neurofibromatosis Type 1 Date: 2008-02-20 Interventions: Drug: Sirolimus This phase II study will evaluate children and adults with neurofibromatosis type-1 (NF1 |